July 2021 - Stablepharma

Özgür Tuncer CEO talks about Developing Thermostable Vaccines To Improve Accessibility Worldwide

Posted on 30 Jul 2021

The challenges related to keeping vaccines adequately cold in many parts of the world has highlighted the need to develop vaccines that are thermostable. In doing so, it would be possible to relieve key bottlenecks in the storage and supply of vaccines, enabling more patients access to the life-saving vaccines they require. Stablepharma has patented […]

Stablepharma partners with the University of Strathclyde to advance their COVID mRNA vaccine thermo-stabilisation technology

Posted on 21 Jul 2021

Stablepharma has partnered with the University of Strathclyde to advance their COVID mRNA vaccine thermo-stabilisation technology following positive recent COVID mRNA stability data Bath, UK, 14 July 2021: A British breakthrough invention could form a crucial part in the urgent quest to combat Covid-19 and future virus pandemics. StablevaX™ allows vaccines to be transported and […]